Description
Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.
Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.
Principal Investigator
Funder
National Institutes of Health - National Cancer Institute
Start Date
July 01, 2018
End Date
June 30, 2021
Related Studies
Beyond Consent: Patient Preferences for Governance and Use of Clinical Data and Samples
Investigator(s): External PI, Principal Investigator
Does the Medicare Preventive Visit Coverage Benefit Seniors With Multiple Chronic Conditions?
Investigator(s): Robert Romanelli, Ph.D., MPH
Effect of Therapeutic Class on Generic Drug Substitutions
Investigators: External PI, Principal Investigator, Robert Romanelli, Ph.D., MPH
Estimating the Costs of Supporting Primary Care Practice Transformation
Investigator(s): Albert S. Chan, M.D., M.S., FAAFP
Exploring Potential Gains and Losses for Providers in a System of Episode-Based Payment in Ambulatory Care
Investigator(s): Harold (Hal) Luft, Ph.D.
Improving American Health Care Affordability and Quality
PCOR -- Applied Research TraNsforming Engaged Real-world Settings (PARTNERS)
Investigator(s): Harold (Hal) Luft, Ph.D.
The Impact of Lean Management on Primary Care Efficiency, Affordability, and the Patient Experience
Investigators: Dorothy Hung, Ph.D., M.A., MPH, Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D.
Time, Referrals, and Doctoring-Efficient Options for the Future (TRADEOFF)
Investigators: Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D.
Towards Aligned Incentives
Investigator(s): Harold (Hal) Luft, Ph.D.